400. Deputy Ken O'Flynn asked the Minister for Health whether the HSE's service level agreement with SouthDoc specifies approved methods for collecting patient fees; whether doctors providing services through SouthDoc are permitted to accept payments into personal accounts, including Revolut; what financial recording, auditing and accountability arrangements apply to such payments; whether SouthDoc is required to pro…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Healthcare Policy.
981 questions match, newest first.
459. Deputy Ken O'Flynn asked the Minister for Health whether consideration has been given to providing a statutory definition of a specialist retailer of nicotine inhaling products, distinguishing premises whose primary business is the sale of such products from general retailers, in view of the difficulty in defining a vape shop identified by the Minister of State with responsibility for public health; whether her …
184. Deputy Mairéad Farrell asked the Minister for Health if she will consider adding Addison's disease to the long-term illness scheme. [74619/26]
874. Deputy David Cullinane asked the Minister for Health whether applications for reimbursement under the cross-border healthcare directive are processed strictly in chronological order according to their date of receipt; if not, the circumstances in which applications may be processed out of sequence; and the way in which applications for other procedures submitted in 2026 have been processed and reimbursed while s…
875. Deputy David Cullinane asked the Minister for Health the number of applications for reimbursement relating to lipoedema treatment under the Cross Border Healthcare Directive that are currently outstanding, broken down by month of receipt from October 2025 to date; the number currently awaiting administrative processing, clinical review or clinical advice respectively; the number processed and reimbursed during t…
876. Deputy David Cullinane asked the Minister for Health the reason any change to the processing, clinical review or eligibility requirements for lipoedema applications under the Cross Border Healthcare Directive was not communicated to patients in advance (details supplied); and if she will make a statement on the matter. [73527/26]
877. Deputy David Cullinane asked the Minister for Health whether applications for reimbursement for lipoedema treatment under the Cross Border Healthcare Directive have been placed on hold, delayed or otherwise prevented from progressing pending clinical review or clinical advice; if so, the date on which this commenced; the reason for the decision; the number of applications affected; the anticipated timeframe for …
878. Deputy David Cullinane asked the Minister for Health whether there has been any change since 29 August 2025 to the assessment, processing or reimbursement of applications relating to the treatment of lipoedema under the Cross Border Healthcare Directive; whether standard applications for treatment of the limbs under the Z01B code are now routinely being referred for clinical review; the date on which any such ch…
883. Deputy Micheál Carrigy asked the Minister for Health whether applications for reimbursement for lipoedema treatment under the cross-border healthcare directive have been placed on hold, delayed or otherwise prevented from progressing pending clinical review or clinical advice; if so, the date on which this commenced; the reason for the decision; the number of applications affected; and the anticipated timeframe …
884. Deputy Micheál Carrigy asked the Minister for Health whether there has been any change since 29 August 2025 to the assessment, processing or reimbursement of applications relating to the treatment of lipoedema under the cross-border healthcare directive; whether standard applications for treatment of the limbs under the Z01B code are now routinely being referred for clinical review; the date on which any such ch…
885. Deputy Micheál Carrigy asked the Minister for Health whether applications for reimbursement under the cross-border healthcare directive are processed strictly in chronological order according to their date of receipt; if not, the circumstances in which applications may be processed out of sequence; and the way in which applications for other procedures submitted in 2026 have been processed and reimbursed while s…
886. Deputy Micheál Carrigy asked the Minister for Health the number of applications for reimbursement relating to lipoedema treatment under the cross-border healthcare directive that are currently outstanding, broken down by month of receipt from October 2025 to date; the number currently awaiting administrative processing, clinical review or clinical advice respectively; the number processed and reimbursed during t…
887. Deputy Micheál Carrigy asked the Minister for Health the reason any change to the processing, clinical review or eligibility requirements for lipoedema applications under the cross-border healthcare directive was not communicated to patients in advance, having regard to the written commitment issued by the National Director of HSE National Services and Schemes on 29 August 2025 that advance notice and published …
894. Deputy Ken O'Flynn asked the Minister for Health the reason Addison’s disease, a chronic condition requiring lifelong hormone replacement therapy and ongoing medical monitoring, is not included in the long-term illness scheme; whether her Department has assessed the financial burden placed on patients who must pay for essential prescribed medication and related treatment; whether consideration will be given to a…
909. Deputy Peadar Tóibín asked the Minister for Health the number of complaints received by the HSE in each of the past five years relating to difficulties accessing follow-up care in the State following treatment received abroad under the Cross-Border Healthcare Directive; and the mechanisms in place to resolve such cases. [73699/26]
910. Deputy Peadar Tóibín asked the Minister for Health the supports available to patients who experience complications arising from treatment obtained under the Cross-Border Healthcare Directive or the treatment abroad scheme; the body responsible for assisting patients where difficulties arise in accessing follow-up care in Ireland after such treatment; and whether any advocacy or support groups are funded or recog…
921. Deputy Ken O'Flynn asked the Minister for Health the steps being taken to measure the time from first presentation to diagnosis of endometriosis as a national performance indicator, in view of the HSE confirming that this figure is not routinely reported; the current waiting times at the supra-regional endometriosis centres at Cork University Maternity Hospital and Tallaght University Hospital; the care pathway …
988. Deputy John Paul O'Shea asked the Minister for Health whether applications for reimbursement under the cross-border healthcare firective are processed strictly in chronological order according to their date of receipt; if not, the circumstances in which applications may be processed out of sequence; and to explain how applications for other procedures submitted in 2026 have been processed and reimbursed while so…
999. Deputy John Paul O'Shea asked the Minister for Health the number of applications for reimbursement relating to lipoedema treatment under the cross-border healthcare directive that are currently outstanding, broken down by month of receipt from October 2025 to date; the number currently awaiting administrative processing, clinical review or clinical advice respectively; the number processed and reimbursed during …
1000. Deputy John Paul O'Shea asked the Minister for Health the reason any change to the processing, clinical review or eligibility requirements for lipoedema applications under the cross-border healthcare directive was not communicated to patients in advance, having regard to the written commitment issued by the National Director of HSE National Services and Schemes on 29th August 2025 that advance notice and publis…
1001. Deputy John Paul O'Shea asked the Minister for Health whether applications for reimbursement for lipoedema treatment under the cross-border healthcare directive have been placed on hold, delayed or otherwise prevented from progressing pending clinical review or clinical advice; if so, the date on which this commenced; the reason for the decision; the number of applications affected; and the anticipated timefram…
1002. Deputy John Paul O'Shea asked the Minister for Health whether there has been any change since 29 August 2025 to the assessment, processing or reimbursement of applications relating to the treatment of lipoedema under the cross-border healthcare directive; whether standard applications for treatment of the limbs under the Z01B code are now routinely being referred for clinical review; the date on which any such …
1025. Deputy Michael Murphy asked the Minister for Health to clarify the statutory responsibilities of the HSE in assessing and communicating public health risks arising from Do Not Consume Notices; whether it is HSE policy to refer media enquiries concerning potential health risks exclusively to Uisce Éireann and the Environmental Protection Agency; and why requests from Tipperary Mid West Radio between 10 and 13 Oc…
1028. Deputy Pa Daly asked the Minister for Health the measures that have been taken to provide nursing home support for survivors of Industrial and Reformatory Schools under the agreement concluded on 10 November 2025; the number of survivors who have benefited from such measures to date; and if she will make a statement on the matter. [74460/26]
1042. Deputy Rose Conway-Walsh asked the Minister for Health the reason changes to the processing, clinical review or eligibility requirements for lipoedema applications under the Cross Border Healthcare Directive were not communicated to patients in advance, having regard to the written commitment issued by the National Director of HSE National Services and Schemes on 29 August 2025 that advance notice and published…